FRABOC Complete Guide: History, Purpose, and Modern Alternatives

FRABOC stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was an Australian tool that helped doctors and nurses check a person’s risk of breast and ovarian cancer based on their family history.

The tool helped healthcare professionals find people who might need more tests or advice from a specialist. However, the original FRABOC tool is now retired. This guide explains what FRABOC was, how it worked, who developed it, and which tools are used today.

What Is FRABOC?

FRABOC was a medical tool used in Australia to check the risk of breast and ovarian cancer. It helped doctors understand whether a person’s family history showed signs of a higher cancer risk.

The tool mainly focused on inherited cancer risk. Some people have a higher chance of developing certain cancers because gene changes can pass from parents to children.

FRABOC used details about family members who had cancer. This included the type of cancer, their age when it was found, and how they were related to the patient.

It placed people into three main risk groups: average or slightly above average risk, moderately increased risk, and potentially high risk. These results helped doctors decide if a person needed more checks or advice from a specialist.

FRABOC was not a cancer test or a genetic test. It could not find cancer or confirm inherited gene changes.

The original tool is no longer available. However, people may still find the name in older medical records and online documents.

Who Developed FRABOC?

FRABOC was developed by Cancer Australia. It is an Australian government agency that works to improve cancer care and provides information about cancer prevention, diagnosis, treatment, and support.

The tool was made for healthcare professionals, mainly general practitioners (GPs) and practice nurses.

These professionals could collect information about a patient’s family history and use it to check possible cancer risk. The results helped them decide if the patient needed further medical advice or a referral to a specialist.

FRABOC was made to support medical decisions, not replace them. Doctors and nurses still needed to consider the patient’s health and other medical details.

The tool was part of Australia’s efforts to identify families who might have a higher risk of inherited breast and ovarian cancer.

Why Was FRABOC Created?

FRABOC was created to help doctors understand how family history can affect a person’s risk of breast and ovarian cancer.

Some cancers are linked to inherited gene changes. These changes can pass from parents to children and increase the chance of developing certain cancers.

For example, changes in the BRCA1 and BRCA2 genes can increase the risk of breast and ovarian cancer. People with these changes may need extra medical checks and further advice.

However, having a family member with cancer does not always mean that the disease is inherited. Doctors also need to consider how many relatives had cancer, their relationship to the patient, and their ages when they were diagnosed.

FRABOC helped healthcare professionals review these family patterns in an organised way.

Its main purposes included:

• Helping doctors review family cancer history.
• Finding possible signs of inherited cancer risk.
• Placing patients into different risk groups.
• Supporting decisions about further medical checks.
• Identifying people who might need specialist advice.
• Helping patients and doctors discuss family cancer history.

The tool made it easier to review family history during medical appointments. However, it could not confirm whether someone would develop cancer.

How Did FRABOC Work?

FRABOC used a person’s family medical history to check their possible risk of breast and ovarian cancer.

A GP or practice nurse collected information about relatives who had been diagnosed with these cancers. They then used this information in the tool to look for possible patterns of inherited risk.

The assessment considered details such as the type of cancer, the age when it was found, and the number of affected family members.

After reviewing the information, FRABOC placed the person into one of three risk groups. The result helped healthcare professionals decide whether more checks or specialist advice might be needed.

Family History Information Used

Family history was the main part of the FRABOC assessment. The tool considered relatives from both the mother’s and father’s sides of the family.

Important details included:

• Close relatives: Parents, brothers, sisters, and children.
• Other relatives: Grandparents, aunts, uncles, and other family members.
• Cancer type: Whether relatives had breast or ovarian cancer.
• Age at diagnosis: How old each person was when cancer was found.
• Multiple cases: Whether several family members had related cancers.
• Male breast cancer: Whether a male family member had breast cancer.
• Cancer in both breasts: Whether a relative had cancer in both breasts.
• Known gene changes: Whether the family had known BRCA1 or BRCA2 gene changes.

Both sides of the family were important because inherited cancer-related gene changes can come from either parent.

Reviewing the Family Cancer Pattern

FRABOC did not look at only one family member. It helped healthcare professionals review the wider family history.

For example, several close relatives with breast or ovarian cancer could suggest a need for further checks. Cancer found at a younger age could also be an important sign.

This information helped doctors understand whether the family had a possible pattern of inherited cancer risk.

Receiving a Risk Category

After reviewing the family information, FRABOC placed the person into one of three risk groups.

The result helped doctors discuss possible next steps with the patient. However, it could not predict exactly who would develop cancer or when it might happen.

FRABOC Risk Categories Explained

FRABOC used three main categories to describe a person’s possible risk of breast and ovarian cancer.

Average or Slightly Above Average Risk

This category meant that the family history did not show strong signs of inherited cancer risk.

People in this group generally followed normal screening advice based on their age and personal health.

However, it did not mean that they could never develop breast or ovarian cancer. It only meant that their family history did not show a clearly increased risk through the FRABOC assessment.

Moderately Increased Risk

This category meant that the person’s family history showed a higher risk than average.

A doctor might suggest a closer review of the family history or discuss suitable screening options.

Some people in this group might need further checks, depending on their family history and other health details.

A moderately increased risk did not mean that the person had cancer or would definitely develop it.

Potentially High Risk

This category suggested that the person’s family history showed stronger signs of possible inherited cancer risk.

A doctor might recommend further checks by a specialist. This could include a referral to a Family Cancer Clinic or genetic counselling service.

Genetic testing might also be discussed if needed. However, a high-risk result did not automatically mean that the person had a BRCA1 or BRCA2 gene change.

Important: These are the old FRABOC risk categories. They should not be used as a current personal cancer risk assessment. Modern tools and medical advice may use different methods.

Was FRABOC a Cancer or Genetic Test?

No. FRABOC was a tool that checked family history to understand possible breast and ovarian cancer risk.

It did not look for cancer cells or tumours. It also did not test DNA or confirm inherited gene changes.

There are important differences between these services:

• FRABOC: Used family history to check possible cancer risk.
• Cancer screening: Checks for possible signs of cancer.
• Genetic testing: Examines DNA to find certain inherited gene changes.
• Cancer diagnosis: Uses medical tests and examinations to confirm whether cancer is present.

For example, someone could receive a potentially high-risk FRABOC result without having cancer. Their doctor might then suggest genetic counselling or further checks.

In the same way, having relatives with cancer does not always mean that someone has an inherited BRCA1 or BRCA2 gene change.

Cancer risk and cancer diagnosis are two different things.

What Happened After a Higher-Risk FRABOC Result?

A higher-risk FRABOC result could lead to further medical checks. The aim was to understand the family history better and decide whether the person needed extra support.

A doctor might recommend a visit to a Family Cancer Clinic. These clinics help people who may have a higher risk of inherited cancer.

Possible next steps included:

• Family history review: Checking the patient’s family cancer history in more detail.
• Genetic counselling: Explaining inherited cancer risks and available tests.
• Genetic testing: Checking for inherited gene changes when needed.
• Screening advice: Discussing suitable cancer checks.
• Prevention guidance: Explaining ways to manage an increased risk.

Not everyone with a higher-risk result needed genetic testing. The next steps depended on the person’s family history and medical advice.

Patients were advised to discuss their results with a doctor instead of making medical decisions based only on FRABOC.

Why Is FRABOC No Longer Available?

The original FRABOC tool is no longer available. Cancer Australia retired it, and healthcare professionals now use other methods to check breast and ovarian cancer risk.

FRABOC helped doctors understand possible cancer risks through family history. Newer tools can use more personal and medical details to provide a more detailed risk assessment.

The exact date when FRABOC was retired has not been clearly confirmed.

Some people may still see FRABOC mentioned in old medical records, referral letters, and online documents. However, these references do not mean the tool is still in use.

Anyone who needs a current cancer risk assessment should speak with a doctor about the available modern tools.

What Replaced FRABOC?

Several modern tools are now used to assess breast cancer and inherited cancer risk. They can consider more information than the old FRABOC system.

Some of the main alternatives include iPrevent, CanRisk, and IBIS (Tyrer-Cuzick).

iPrevent

iPrevent is a modern breast cancer risk assessment tool developed by Peter MacCallum Cancer Centre in Australia.

It looks at several personal and family health details. These can include family cancer history, reproductive history, breast density, and lifestyle factors.

The tool can estimate a person’s breast cancer risk over five years and during their lifetime. It can also help doctors discuss suitable screening and risk management options.

iPrevent is useful for people who need a more detailed breast cancer risk assessment. Its results should always be discussed with a healthcare professional.

CanRisk

CanRisk is a tool used to assess inherited cancer risk. It is based on the BOADICEA model.

It uses family history and genetic information to help estimate the risk of breast and ovarian cancer.

CanRisk can be useful when several family members have had cancer or when a family has known inherited gene changes. It helps healthcare professionals review more complex family cancer histories.

Unlike the old FRABOC tool, CanRisk can use more detailed information to provide personalised risk estimates. It is mainly used in professional healthcare settings.

IBIS (Tyrer-Cuzick)

IBIS, also known as the Tyrer-Cuzick model, is used to estimate a person’s breast cancer risk.

It considers family history and other personal health details. This helps provide a more detailed risk estimate than a basic family history assessment.

Healthcare professionals may use IBIS when checking breast cancer risk and discussing whether additional screening is needed.

The main difference is that IBIS considers a wider range of risk factors instead of placing people into only three broad categories, as FRABOC did.

FRABOC vs Modern Cancer Risk Assessment Tools

FRABOC and modern cancer risk tools have a similar purpose. They help healthcare professionals understand whether someone may have a higher risk of breast or ovarian cancer.

However, they use different methods. FRABOC mainly focused on family history, while newer tools can also consider personal health details and genetic information.

Here is a simple comparison:

The main difference is the amount of information each tool can use. FRABOC gave broad risk categories, while modern tools can provide more detailed risk estimates.

However, these tools are not exactly the same. The right option depends on the person’s medical history and the type of assessment needed.

How to Prepare for a Family Cancer Risk Assessment

If you are visiting a doctor to discuss breast or ovarian cancer risk, preparing your family history can make the appointment easier.

Try to collect information about relatives who have had cancer. Include family members from both your mother’s and father’s sides.

Useful details include:

• Family relationships: Which relatives had cancer?
• Cancer type: Was it breast, ovarian, or another type of cancer?
• Age at diagnosis: How old were they when cancer was found?
• Multiple diagnoses: Did any relative have more than one type of cancer?
• Previous genetic testing: Are there any BRCA1 or BRCA2 test reports?
• Medical records: Do you have any useful family medical documents?

You do not need to know every detail before visiting your doctor. Even some family information can help start the discussion.

A simple family tree can also make it easier to explain which relatives were affected.

Your doctor may ask more questions and decide whether you need further checks or a referral to a specialist.

Is Family History Enough to Know Your Cancer Risk?

Family history is important when checking the risk of breast and ovarian cancer. However, it does not tell the whole story.

Some people develop these cancers without any known family history. Others have several relatives with cancer but do not have a known inherited gene change.

This is why doctors look at other details when checking someone’s risk.

They may consider:

• How many relatives had cancer.
• Which types of cancer were found in the family.
• The ages of relatives when they were diagnosed.
• Whether cancer affected relatives on both sides of the family.
• Known inherited gene changes.
• Personal health and reproductive history.

Changes in the BRCA1 and BRCA2 genes can increase the risk of certain cancers. These changes can pass from either parent.

Having one relative with cancer does not automatically mean that someone has a high inherited risk. In the same way, having no known family history does not mean that the risk is zero.

A healthcare professional can review these details and decide whether further assessment is needed.

Can You Still Use Old FRABOC Results?

Old FRABOC results may still be useful as part of a person’s medical history. They can show that a family cancer risk assessment was carried out in the past.

However, these results should not be treated as a current risk estimate.

Family health information can change over time. New cancer cases in the family, genetic test results, and personal health details may affect a person’s risk.

Modern tools can also consider more information than the old FRABOC system.

If you have an old FRABOC report, show it to your doctor. They can review the information and decide whether you need a new assessment.

Do not make decisions about screening, genetic testing, or treatment based only on an old FRABOC result.

Bottom Line

FRABOC was an Australian tool developed by Cancer Australia to help doctors and nurses check family-related breast and ovarian cancer risk.

It used family medical history to place people into three risk groups. These results helped healthcare professionals decide whether further checks or specialist advice might be needed.

The original tool has now been retired. Modern options such as iPrevent, CanRisk, and IBIS offer other ways to assess cancer risk using family history and additional health information.

Anyone with an old FRABOC result or concerns about inherited cancer risk should discuss them with a qualified healthcare professional.

Frequently Asked Questions

What does FRABOC stand for?

FRABOC means Familial Risk Assessment – Breast and Ovarian Cancer. It was used to check cancer risk through family history.

What was FRABOC used for?

It helped doctors check if someone had a higher risk of breast or ovarian cancer based on their family history.

Who developed FRABOC?

Cancer Australia developed FRABOC for doctors and nurses.

Is FRABOC still available?

No. FRABOC has been retired. Modern tools are now used to check cancer risk.

What replaced FRABOC?

iPrevent, CanRisk, and IBIS are modern tools used to check breast cancer risk.

Was FRABOC a genetic test?

No. It checked family history but did not test DNA or find gene changes.

Does a high FRABOC result mean someone has cancer?

No. It only showed that further checks might be needed. It did not mean someone had cancer.

Can old FRABOC results still be useful?

Yes. Old results can help doctors understand your family history, but they may need a new assessment.

Explore More:

Coyyn.com Guide: What the Platform Offers and How It Works